The prognostic potential of alternative transcript isoforms across human tumors.

Abstract:

BACKGROUND:Phenotypic changes during cancer progression are associated with alterations in gene expression, which can be exploited to build molecular signatures for tumor stage identification and prognosis. However, it is not yet known whether the relative abundance of transcript isoforms may be informative for clinical stage and survival. METHODS:Using information theory and machine learning methods, we integrated RNA sequencing and clinical data from The Cancer Genome Atlas project to perform the first systematic analysis of the prognostic potential of transcript isoforms in 12 solid tumors to build new signatures for stage and prognosis. This study was also performed in breast tumors according to estrogen receptor (ER) status and melanoma tumors with proliferative and invasive phenotypes. RESULTS:Transcript isoform signatures accurately separate early from late-stage groups and metastatic from non-metastatic tumors, and are predictive of the survival of patients with undetermined lymph node invasion or metastatic status. These signatures show similar, and sometimes better, accuracies compared with known gene expression signatures in retrospective data and are largely independent of gene expression changes. Furthermore, we show frequent transcript isoform changes in breast tumors according to ER status, and in melanoma tumors according to the invasive or proliferative phenotype, and derive accurate predictive models of stage and survival within each patient subgroup. CONCLUSIONS:Our analyses reveal new signatures based on transcript isoform abundances that characterize tumor phenotypes and their progression independently of gene expression. Transcript isoform signatures appear especially relevant to determine lymph node invasion and metastasis and may potentially contribute towards current strategies of precision cancer medicine.

journal_name

Genome Med

journal_title

Genome medicine

authors

Trincado JL,Sebestyén E,Pagés A,Eyras E

doi

10.1186/s13073-016-0339-3

subject

Has Abstract

pub_date

2016-08-17 00:00:00

pages

85

issue

1

issn

1756-994X

pii

10.1186/s13073-016-0339-3

journal_volume

8

pub_type

杂志文章
  • Epigenetic therapy of myelodysplastic syndromes connects to cellular differentiation independently of endogenous retroelement derepression.

    abstract:BACKGROUND:Myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML) are characterised by abnormal epigenetic repression and differentiation of bone marrow haematopoietic stem cells (HSCs). Drugs that reverse epigenetic repression, such as 5-azacytidine (5-AZA), induce haematological improvement in half of trea...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-019-0707-x

    authors: Kazachenka A,Young GR,Attig J,Kordella C,Lamprianidou E,Zoulia E,Vrachiolias G,Papoutselis M,Bernard E,Papaemmanuil E,Kotsianidis I,Kassiotis G

    更新日期:2019-12-23 00:00:00

  • DNA methylation-based chromatin compartments and ChIP-seq profiles reveal transcriptional drivers of prostate carcinogenesis.

    abstract:BACKGROUND:Profiles of DNA methylation of many tissues relevant in human disease have been obtained from microarrays and are publicly available. These can be used to generate maps of chromatin compartmentalization, demarcating open and closed chromatin across the genome. Additionally, large sets of genome-wide transcri...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-017-0443-z

    authors: Simmonds P,Loomis E,Curry E

    更新日期:2017-06-07 00:00:00

  • Novel insights into the HLA class I immunopeptidome and T-cell immunosurveillance.

    abstract::Advances in mass spectrometry have allowed the high-throughput quantitative identification of human leukocyte antigen (HLA) class I ligands, and recent studies have reported on the breadth and diversity of the HLA class I immunopeptidome. These findings have far-reaching implications for immunosurveillance by T cells ...

    journal_title:Genome medicine

    pub_type: 社论,评审

    doi:10.1186/s13073-017-0439-8

    authors: Melief CJM,Kessler JH

    更新日期:2017-05-24 00:00:00

  • Using inactivating mutations to provide insight into drug action.

    abstract::The role of ezetimibe in lowering plasma cholesterol has been established; however, controversy remains about its clinical benefit. A recent study utilizes naturally occurring genetic variation within the NPC1-like 1 gene (NPC1L1) to demonstrate the potential for pharmacologic inhibition of the protein to reduce the r...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-015-0130-x

    authors: Corbin LJ,Timpson NJ

    更新日期:2015-01-28 00:00:00

  • Hematopoietic stem cells, hematopoiesis and disease: lessons from the zebrafish model.

    abstract::The zebrafish model is rapidly gaining prominence in the study of development, hematopoiesis, and disease. The zebrafish provides distinct advantages over other vertebrate models during early embryonic development by producing transparent, externally fertilized embryos. Embryonic zebrafish are easily visualized and ma...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm299

    authors: Martin CS,Moriyama A,Zon LI

    更新日期:2011-12-29 00:00:00

  • A Klebsiella pneumoniae ST307 outbreak clone from Germany demonstrates features of extensive drug resistance, hypermucoviscosity, and enhanced iron acquisition.

    abstract:BACKGROUND:Antibiotic-resistant Klebsiella pneumoniae are a major cause of hospital- and community-acquired infections, including sepsis, liver abscess, and pneumonia, driven mainly by the emergence of successful high-risk clonal lineages. The K. pneumoniae sequence type (ST) 307 lineage has appeared in several differe...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-020-00814-6

    authors: Heiden SE,Hübner NO,Bohnert JA,Heidecke CD,Kramer A,Balau V,Gierer W,Schaefer S,Eckmanns T,Gatermann S,Eger E,Guenther S,Becker K,Schaufler K

    更新日期:2020-12-09 00:00:00

  • Optimizing the treatment of BRAF mutant melanoma.

    abstract::Selective inhibitors of the kinases BRAF and MEK for the treatment of patients with otherwise refractory BRAF mutant melanoma have demonstrated impressive efficacy, and combination treatment with these agents may prove to be even more effective. However, these drugs are not curative, mainly because of the relatively r...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm547

    authors: Settleman J

    更新日期:2014-04-28 00:00:00

  • Exploiting the noise: improving biomarkers with ensembles of data analysis methodologies.

    abstract:BACKGROUND:The advent of personalized medicine requires robust, reproducible biomarkers that indicate which treatment will maximize therapeutic benefit while minimizing side effects and costs. Numerous molecular signatures have been developed over the past decade to fill this need, but their validation and up-take into...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm385

    authors: Starmans MH,Pintilie M,John T,Der SD,Shepherd FA,Jurisica I,Lambin P,Tsao MS,Boutros PC

    更新日期:2012-11-12 00:00:00

  • NGS-Logistics: federated analysis of NGS sequence variants across multiple locations.

    abstract::As many personal genomes are being sequenced, collaborative analysis of those genomes has become essential. However, analysis of personal genomic data raises important privacy and confidentiality issues. We propose a methodology for federated analysis of sequence variants from personal genomes. Specific base-pair posi...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-014-0071-9

    authors: Ardeshirdavani A,Souche E,Dehaspe L,Van Houdt J,Vermeesch JR,Moreau Y

    更新日期:2014-09-17 00:00:00

  • Digital transcriptome profiling of normal and glioblastoma-derived neural stem cells identifies genes associated with patient survival.

    abstract:BACKGROUND:Glioblastoma multiforme, the most common type of primary brain tumor in adults, is driven by cells with neural stem (NS) cell characteristics. Using derivation methods developed for NS cells, it is possible to expand tumorigenic stem cells continuously in vitro. Although these glioblastoma-derived neural ste...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm377

    authors: Engström PG,Tommei D,Stricker SH,Ender C,Pollard SM,Bertone P

    更新日期:2012-10-09 00:00:00

  • Estimating exome genotyping accuracy by comparing to data from large scale sequencing projects.

    abstract::With exome sequencing becoming a tool for mutation detection in routine diagnostics there is an increasing need for platform-independent methods of quality control. We present a genotype-weighted metric that allows comparison of all the variant calls of an exome to a high-quality reference dataset of an ethnically mat...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm473

    authors: Heinrich V,Kamphans T,Stange J,Parkhomchuk D,Hecht J,Dickhaus T,Robinson PN,Krawitz PM

    更新日期:2013-07-31 00:00:00

  • Genome-wide association studies are coming for human infectious diseases.

    abstract::A genetic contribution to infectious disease in human populations has long been suspected and is now supported by more than 50 years of epidemiological evidence showing, for example, infection rates to be much higher than disease rates. In successful family studies of high-penetrance effects, single gene mutations hav...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm19

    authors: Davila S,Hibberd ML

    更新日期:2009-02-10 00:00:00

  • Interrogating the "unsequenceable" genomic trinucleotide repeat disorders by long-read sequencing.

    abstract::Microsatellite expansion, such as trinucleotide repeat expansion (TRE), is known to cause a number of genetic diseases. Sanger sequencing and next-generation short-read sequencing are unable to interrogate TRE reliably. We developed a novel algorithm called RepeatHMM to estimate repeat counts from long-read sequencing...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-017-0456-7

    authors: Liu Q,Zhang P,Wang D,Gu W,Wang K

    更新日期:2017-07-18 00:00:00

  • Polygenic risk scores: from research tools to clinical instruments.

    abstract::Genome-wide association studies have shown unequivocally that common complex disorders have a polygenic genetic architecture and have enabled researchers to identify genetic variants associated with diseases. These variants can be combined into a polygenic risk score that captures part of an individual's susceptibilit...

    journal_title:Genome medicine

    pub_type: 杂志文章,评审

    doi:10.1186/s13073-020-00742-5

    authors: Lewis CM,Vassos E

    更新日期:2020-05-18 00:00:00

  • Pan-cancer identification of clinically relevant genomic subtypes using outcome-weighted integrative clustering.

    abstract:BACKGROUND:Comprehensive molecular profiling has revealed somatic variations in cancer at genomic, epigenomic, transcriptomic, and proteomic levels. The accumulating data has shown clearly that molecular phenotypes of cancer are complex and influenced by a multitude of factors. Conventional unsupervised clustering appl...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-020-00804-8

    authors: Arora A,Olshen AB,Seshan VE,Shen R

    更新日期:2020-12-03 00:00:00

  • The three-body problem of therapy with induced pluripotent stem cells.

    abstract::Regenerative medicine has a three-body problem: alignment of the dynamics of the genome, stem cell and patient. Focusing on the rare inherited fragile skin disorder epidermolysis bullosa, three recent innovative studies have used induced pluripotent stem cells and gene correction, revertant mosaicism or genome editing...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-015-0141-7

    authors: Tolar J,McGrath JA

    更新日期:2015-02-20 00:00:00

  • Mode and dynamics of vanA-type vancomycin resistance dissemination in Dutch hospitals.

    abstract:BACKGROUND:Enterococcus faecium is a commensal of the gastrointestinal tract of animals and humans but also a causative agent of hospital-acquired infections. Resistance against glycopeptides and to vancomycin has motivated the inclusion of E. faecium in the WHO global priority list. Vancomycin resistance can be confer...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-020-00825-3

    authors: Arredondo-Alonso S,Top J,Corander J,Willems RJL,Schürch AC

    更新日期:2021-01-20 00:00:00

  • Moderate- to low-risk variant alleles of cutaneous malignancies and nevi: lessons from genome-wide association studies.

    abstract::Cutaneous malignancies, especially malignant melanoma, exhibit great genetic heterogeneity. As a result, some individuals and families have particularly increased risk due to genetic predisposition to the disease. The susceptibility alleles range from rarely occurring, heritable, high-risk variants to ubiquitously occ...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm95

    authors: Udayakumar D,Tsao H

    更新日期:2009-10-27 00:00:00

  • Three periods of one and a half decade of ischemic stroke susceptibility gene research: lessons we have learned.

    abstract::Candidate gene association studies, linkage studies and genome-wide association studies have highlighted the role of genetic factors in the development of ischemic stroke. This research started over a decade ago, and can be separated into three major periods of research. In the first wave classic susceptibility marker...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm185

    authors: Maasz A,Melegh B

    更新日期:2010-09-13 00:00:00

  • Microbiome mediation of infections in the cancer setting.

    abstract::Infections encountered in the cancer setting may arise from intensive cancer treatments or may result from the cancer itself, leading to risk of infections through immune compromise, disruption of anatomic barriers, and exposure to nosocomial (hospital-acquired) pathogens. Consequently, cancer-related infections are u...

    journal_title:Genome medicine

    pub_type: 杂志文章,评审

    doi:10.1186/s13073-016-0306-z

    authors: Taur Y,Pamer EG

    更新日期:2016-04-18 00:00:00

  • Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations.

    abstract:BACKGROUND:Chemotherapeutic agents such as anthracyclines and taxanes are commonly used in the neoadjuvant setting. Bevacizumab is an antibody which binds to vascular endothelial growth factor A (VEGFA) and inhibits its receptor interaction, thus obstructing the formation of new blood vessels. METHODS:A phase II rando...

    journal_title:Genome medicine

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1186/s13073-018-0601-y

    authors: Höglander EK,Nord S,Wedge DC,Lingjærde OC,Silwal-Pandit L,Gythfeldt HV,Vollan HKM,Fleischer T,Krohn M,Schlitchting E,Borgen E,Garred Ø,Holmen MM,Wist E,Naume B,Van Loo P,Børresen-Dale AL,Engebraaten O,Kristensen V

    更新日期:2018-11-29 00:00:00

  • DNA methylation signature in blood mirrors successful weight-loss during lifestyle interventions: the CENTRAL trial.

    abstract:BACKGROUND:One of the major challenges in obesity treatment is to explain the high variability in the individual's response to specific dietary and physical activity interventions. With this study, we tested the hypothesis that specific DNA methylation changes reflect individual responsiveness to lifestyle intervention...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-020-00794-7

    authors: Keller M,Yaskolka Meir A,Bernhart SH,Gepner Y,Shelef I,Schwarzfuchs D,Tsaban G,Zelicha H,Hopp L,Müller L,Rohde K,Böttcher Y,Stadler PF,Stumvoll M,Blüher M,Kovacs P,Shai I

    更新日期:2020-11-16 00:00:00

  • Clinical laboratory test-wide association scan of polygenic scores identifies biomarkers of complex disease.

    abstract:BACKGROUND:Clinical laboratory (lab) tests are used in clinical practice to diagnose, treat, and monitor disease conditions. Test results are stored in electronic health records (EHRs), and a growing number of EHRs are linked to patient DNA, offering unprecedented opportunities to query relationships between genetic ri...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-020-00820-8

    authors: Dennis JK,Sealock JM,Straub P,Lee YH,Hucks D,Actkins K,Faucon A,Feng YA,Ge T,Goleva SB,Niarchou M,Singh K,Morley T,Smoller JW,Ruderfer DM,Mosley JD,Chen G,Davis LK

    更新日期:2021-01-13 00:00:00

  • MeCP2 mutations: progress towards understanding and treating Rett syndrome.

    abstract::Rett syndrome is a profound neurological disorder caused by mutations in the MECP2 gene, but preclinical research has indicated that it is potentially treatable. Progress towards this goal depends on the development of increasingly relevant model systems and on our improving knowledge of MeCP2 function in the brain. ...

    journal_title:Genome medicine

    pub_type: 信件,评审

    doi:10.1186/s13073-017-0411-7

    authors: Shah RR,Bird AP

    更新日期:2017-02-17 00:00:00

  • Open science versus commercialization: a modern research conflict?

    abstract:BACKGROUND:Efforts to improve research outcomes have resulted in genomic researchers being confronted with complex and seemingly contradictory instructions about how to perform their tasks. Over the past decade, there has been increasing pressure on university researchers to commercialize their work. Concurrently, they...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm316

    authors: Caulfield T,Harmon SH,Joly Y

    更新日期:2012-02-27 00:00:00

  • DawnRank: discovering personalized driver genes in cancer.

    abstract::Large-scale cancer genomic studies have revealed that the genetic heterogeneity of the same type of cancer is greater than previously thought. A key question in cancer genomics is the identification of driver genes. Although existing methods have identified many common drivers, it remains challenging to predict person...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-014-0056-8

    authors: Hou JP,Ma J

    更新日期:2014-07-31 00:00:00

  • Killer-cell Immunoglobulin-like Receptor gene linkage and copy number variation analysis by droplet digital PCR.

    abstract::The Killer-cell Immunoglobulin-like Receptor (KIR) gene complex has considerable biomedical importance. Patterns of polymorphism in the KIR region include variability in the gene content of haplotypes and diverse structural arrangements. Droplet digital PCR (ddPCR) was used to identify different haplotype motifs and t...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm537

    authors: Roberts CH,Jiang W,Jayaraman J,Trowsdale J,Holland MJ,Traherne JA

    更新日期:2014-03-05 00:00:00

  • Systems and genome-wide approaches unite to provide a route to personalized medicine.

    abstract::A report on the Keystone Symposium 'Complex Traits: Genomics and Computational approaches', Breckenridge, Colorado, USA, 20-25 February 2012. ...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm328

    authors: Stranger BE,Björkegren J,Dolan ME,Ritchie MD

    更新日期:2012-03-30 00:00:00

  • Consensus: a framework for evaluation of uncertain gene variants in laboratory test reporting.

    abstract::Accurate interpretation of gene testing is a key component in customizing patient therapy. Where confirming evidence for a gene variant is lacking, computational prediction may be employed. A standardized framework, however, does not yet exist for quantitative evaluation of disease association for uncertain or novel g...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm347

    authors: Crockett DK,Ridge PG,Wilson AR,Lyon E,Williams MS,Narus SP,Facelli JC,Mitchell JA

    更新日期:2012-05-28 00:00:00

  • Stem cell banking: between traceability and identifiability.

    abstract::Stem cell banks are increasingly seen as an essential resource of biological materials for both basic and translational research. Stem cell banks support transnational access to quality-controlled and ethically sourced stem cell lines from different origins and of varying grades. According to the Organisation for Econ...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm194

    authors: Knoppers BM,Isasi R

    更新日期:2010-10-05 00:00:00